Going Viral
Going Viral: The Future of Human Health, Pandemic Resilience and Biowarfare
Join us to discuss the most important topic of last year, of this year, and possibly every future year to come. COVID-19. Viruses. mRNA Vaccines. Synthetic Biology. Pandemic Resilience. And the very real threats and opportunities around Biosecurity and Biowarfare.
We have two rockstar speakers joining us for what promises to be a discussion for the ages. Milana Boukhman Trounce, MD, MBA and Gigi Kwik Gronvall, PhD have been leading key COVID-19 initiatives at their respective institutions, Stanford and Johns Hopkins. They teach, research, speak, lead, and generally drop the mic on all things “viral.”
With unique lenses on infectious disease, public health, and biowarfare, Drs. Trounce and Gronvall are sure to enlighten us on the topics we ignore only at our own peril. They also have the training and vantage point to shed light and hope on our current predicament and share wisdom on how we can elevate our resilience, as a species, as a nation, and as a planet, in the face of future bio-events.
Cota Access is a recurring webinar that we host several times a year, where we bring together founders, thought leaders, and leading executives to explore a variety of business and technology trends and topics that fundamentally impact large enterprises.
Cota Capital is an SEC-registered, multi-stage investment firm based in San Francisco, focused on US-based modern enterprise technology. Cota has invested in over 75 private and 25 public technology companies since its inception in 2015, in the fields of infrastructure, workflow automation & applications, fintech, and healthtech.
Learn more about Cota Capital.
Follow Cota Capital on Medium.
Watch past Cota Access events and Cota Podcasts.
We look forward to seeing you there!
Disclaimer
In addition to my affiliation with Cota as an Operating Partner, my podcast guests may also have similar or other affiliations with Cota. The views expressed are my own views and the views of my guests, and do not necessarily reflect the views of Cota or any of its affiliates. Some of the information presented may have been provided by, or obtained from, third parties. While we strive to be accurate, neither we nor Cota guarantee the accuracy or completeness of the information.
You should not construe any of this information as investment advice. Neither Cota, me nor my guests are acting as investment advisers or otherwise making any recommendation to invest in any security. The information may include forward-looking information or predictions about future events, such as technological trends. Such statements are not guarantees of future results and are subject to certain risks, uncertainties and assumptions that are difficult to predict.
The information presented will become stale over time. Neither Cota, me nor my guests are obligated to revise or update any information for any reason or to notify you of any such change, revision or update.
